These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29446256)
1. Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations. Emoto C; Johnson TN; McPhail BT; Vinks AA; Fukuda T CPT Pharmacometrics Syst Pharmacol; 2018 Apr; 7(4):237-250. PubMed ID: 29446256 [TBL] [Abstract][Full Text] [Related]
2. Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition. Emoto C; Johnson TN; Yamada T; Yamazaki H; Fukuda T Eur J Clin Pharmacol; 2021 Aug; 77(8):1157-1168. PubMed ID: 33527208 [TBL] [Abstract][Full Text] [Related]
3. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population. Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145 [TBL] [Abstract][Full Text] [Related]
4. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients. Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606 [TBL] [Abstract][Full Text] [Related]
5. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach. Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652 [TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients. Cui C; Li X; Liang H; Hou Z; Tu S; Dong Z; Yao X; Zhang M; Zhang X; Li H; Zuo X; Liu D Biopharm Drug Dispos; 2021 Jan; 42(1):24-34. PubMed ID: 33340419 [TBL] [Abstract][Full Text] [Related]
7. A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest. Zane NR; Reedy MD; Gastonguay MR; Himebauch AS; Ramsey EZ; Topjian AA; Zuppa AF Pediatr Crit Care Med; 2017 Jul; 18(7):e290-e297. PubMed ID: 28481829 [TBL] [Abstract][Full Text] [Related]
9. New insights into the vancomycin-induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling. Du H; Li Z; Yang Y; Li X; Wei Y; Lin Y; Zhuang X J Appl Toxicol; 2020 Jul; 40(7):897-907. PubMed ID: 32079046 [TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling. Nakamaru Y; Emoto C; Shimizu M; Yamazaki H Biopharm Drug Dispos; 2015 Apr; 36(3):148-62. PubMed ID: 25450725 [TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations. Rhee SJ; Chung H; Yi S; Yu KS; Chung JY Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):973-980. PubMed ID: 28536774 [TBL] [Abstract][Full Text] [Related]
12. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation. Lim HS; Chong YP; Noh YH; Jung JA; Kim YS J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720 [TBL] [Abstract][Full Text] [Related]
13. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol. T'jollyn H; Vermeulen A; Van Bocxlaer J AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862 [TBL] [Abstract][Full Text] [Related]
14. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women. De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128 [TBL] [Abstract][Full Text] [Related]
15. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Lamarre P; Lebel D; Ducharme MP Antimicrob Agents Chemother; 2000 Feb; 44(2):278-82. PubMed ID: 10639350 [TBL] [Abstract][Full Text] [Related]
16. Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Maglalang PD; Sinha J; Zimmerman K; McCann S; Edginton A; Hornik CP; Hornik CD; Muller WJ; Al-Uzri A; Meyer M; Chen JY; Anand R; Perrin EM; Gonzalez D; Clin Pharmacokinet; 2024 Jun; 63(6):885-899. PubMed ID: 38814425 [TBL] [Abstract][Full Text] [Related]
17. Physiologically-based pharmacokinetic model for alectinib, ruxolitinib, and panobinostat in the presence of cancer, renal impairment, and hepatic impairment. Alsmadi MM; Al-Daoud NM; Jaradat MM; Alzughoul SB; Abu Kwiak AD; Abu Laila SS; Abu Shameh AJ; Alhazabreh MK; Jaber SA; Abu Kassab HT Biopharm Drug Dispos; 2021 Jun; 42(6):263-284. PubMed ID: 33904202 [TBL] [Abstract][Full Text] [Related]
19. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817 [TBL] [Abstract][Full Text] [Related]
20. Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions. Huang W; Nakano M; Sager J; Ragueneau-Majlessi I; Isoherranen N Drug Metab Dispos; 2017 Nov; 45(11):1156-1165. PubMed ID: 28860113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]